Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational study.

MLA

Tang, Huilin, et al. “Heterogeneous Treatment Effects of Metformin on Risk of Dementia in Patients with Type 2 Diabetes: A Longitudinal Observational Study.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, vol. 20, no. 2, Feb. 2024, pp. 975–85. EBSCOhost, https://doi.org/10.1002/alz.13480.

APA

Tang, H., Guo, J., Shaaban, C. E., Feng, Z., Wu, Y., Magoc, T., Hu, X., Donahoo, W. T., DeKosky, S. T., & Bian, J. (2024). Heterogeneous treatment effects of metformin on risk of dementia in patients with type 2 diabetes: A longitudinal observational study. Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association, 20(2), 975–985. https://doi.org/10.1002/alz.13480

Chicago

Tang, Huilin, Jingchuan Guo, C Elizabeth Shaaban, Zheng Feng, Yonghui Wu, Tanja Magoc, Xia Hu, William T Donahoo, Steven T DeKosky, and Jiang Bian. 2024. “Heterogeneous Treatment Effects of Metformin on Risk of Dementia in Patients with Type 2 Diabetes: A Longitudinal Observational Study.” Alzheimer’s & Dementia : The Journal of the Alzheimer’s Association 20 (2): 975–85. doi:10.1002/alz.13480.